Magnetoliposomes containing magnesium ferrite nanoparticles as nanocarriers for the mode drug curcumin

Magnesium ferrite nanoparticles, with diameters around 25 nm, were synthesized by coprecipitation method. The magnetic properties indicate a superparamagnetic behavior, with a maximum magnetization of 16.2 emu/g, a coercive field of 22.1 Oe and a blocking temperature of 183.2 K. These MgFe2O4 nanopa...

ver descrição completa

Detalhes bibliográficos
Autor principal: Cardoso, Beatriz D. (author)
Outros Autores: Rio, Irina S. R. (author), Rodrigues, Ana Rita Oliveira (author), Fernandes, Francisca C. T. (author), Almeida, B. G. (author), Pires, A. (author), Pereira, A. M. (author), Araújo, J. P. (author), Castanheira, Elisabete M. S. (author), Coutinho, Paulo J. G. (author)
Formato: article
Idioma:eng
Publicado em: 2018
Assuntos:
Texto completo:http://hdl.handle.net/1822/56615
País:Portugal
Oai:oai:repositorium.sdum.uminho.pt:1822/56615
Descrição
Resumo:Magnesium ferrite nanoparticles, with diameters around 25 nm, were synthesized by coprecipitation method. The magnetic properties indicate a superparamagnetic behavior, with a maximum magnetization of 16.2 emu/g, a coercive field of 22.1 Oe and a blocking temperature of 183.2 K. These MgFe2O4 nanoparticles were used to produce aqueous and solid magnetoliposomes, with sizes below 130 nm. The potential drug curcumin was successfully incorporated in these nanosystems, with high encapsulation efficiencies (above 89%). Interaction by fusion between both types of drug loaded magnetoliposomes (with or without PEGylation) and models of biological membranes was demonstrated, using FRET or fluorescence quenching assays. These results point to future applications of magnetoliposomes containing MgFe2O4 nanoparticles in cancer therapy, allowing combined magnetic hyperthermia and chemotherapy.